Medical Science News

RSS

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced a strategic collaboration to accelerate the discovery and development of innovative therapeutic antibodies, leveraging their respective technological strengths in antibody discovery and artificial intelligence.

21 Feb 2025

Engineered blood vessel cells boost islet transplant success in diabetes treatment

Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a preclinical study led by Weill Cornell Medicine investigators.

21 Feb 2025

Targeted mRNA therapy shows promise for healing damaged lungs

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

21 Feb 2025

Study reveals how breathing regulates pupil size and vision

Researchers at Karolinska Institutet in Sweden have discovered a fundamental mechanism that affects the size of the pupil, namely our breathing.

21 Feb 2025

Antioxidant-enzyme interactions and their role in non-communicable diseases

Oxidative stress, caused by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, plays a central role in the development of non-communicable diseases (NCDs).

21 Feb 2025

Targeting FGFR mutations offers new hope for bone repair in skeletal disorders

Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders, such as craniosynostosis and chondrodysplasia, which severely affect craniofacial and mandibular development.

21 Feb 2025

Exploring EGCG's role in protecting against acetaminophen-induced liver injury

Announcing a new publication for Acta Materia Medica journal. Excessive consumption of acetaminophen (APAP) has emerged as the primary culprit behind drug-induced liver injury (DILI), with N-acetylcysteine serving as the principal antidote.

21 Feb 2025

Early gut microbiota linked to food sensitivities in infants

A study led by Hiroshi Ohno at the RIKEN Center for Integrative Medical Sciences (IMS) recently showed that certain gut bacteria found in one-month-old infants are associated with food sensitivities and the development of food allergies, particularly to eggs, while other types of bacteria are not.

21 Feb 2025

Key research priorities for understanding and treating appendiceal cancer

Appendiceal cancer is a rare cancer without standardized screening guidelines, risk factors or tumor classifications - a situation that often results in late diagnosis and poor prognosis.

21 Feb 2025

Mathematicians explore how brain folding helps improve brainpower

Mathematicians are investigating how the intricate folds in the human brain – which have increased as our species has evolved – help to improve our brainpower.

21 Feb 2025

New 3D lung model advances respiratory medicine research

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in the lungs at the correct dosage.

20 Feb 2025

Exploring how 25-hydroxycholesterol triggers ferroptosis in glial cells

Oxysterols are a class of molecules derived from cholesterol via oxidation or as byproducts of cholesterol synthesis.

20 Feb 2025

Narcissists feel left out more often—but are they misreading the room?

Narcissists are more likely to feel ostracized—not only because of their personalities but also due to their heightened sensitivity to exclusion cues. Research finds that social exclusion and narcissism reinforce each other in a self-perpetuating cycle.

20 Feb 2025

CBD boosts endurance in mice by reshaping gut bacteria and enhancing muscle performance

Study shows that cannabidiol (CBD) enhances endurance exercise in mice by reshaping gut microbiota, boosting mitochondrial function, and altering muscle fiber composition for improved performance.

20 Feb 2025

Eating more flavonoids may slow aging and boost brain health, study finds

A high intake of flavonoid-rich foods, such as tea, apples, blueberries, and red wine, is linked to reduced risks of frailty, poor mental health, and physical impairment in older adults, particularly women.

20 Feb 2025

Olive oil prevents weight gain while butter and margarine add pounds, study finds

A long-term study of 121,119 participants found that increasing olive oil intake was associated with less weight gain over time, while consuming margarine, butter, and vegetable oils led to greater weight gain.

20 Feb 2025

Can chili peppers improve ADHD symptoms? Scientists explore their gut-brain connection

Chili peppers may influence ADHD symptoms by modulating the gut microbiome, with capsaicin, vitamin C, and omega-3 fatty acids showing potential effects on neurotransmitters and inflammation. However, clinical trials are needed to confirm their efficacy.

20 Feb 2025

An avocado a day won’t fix heart health, but it boosts diet and sleep

A randomized controlled trial found that daily avocado consumption for 26 weeks did not significantly improve overall cardiovascular health (LE8 score) but did enhance diet quality, sleep health, and blood lipids.

20 Feb 2025

New approach shows promise for treating fragile X syndrome

Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, the most common genetically-caused autism spectrum disorder.

20 Feb 2025

Breakthrough discovery unveils potential treatment for hepatitis B

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine and The Rockefeller University identified a vulnerability that opens the door to new treatments.

20 Feb 2025